The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Abstract
PURPOSE: This study was performed to evaluate the potential of specific mRNA markers to detect micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) and Southern blot analysis of sentinel lymph nodes (SNs) and blood from patients with breast cancer. PATIENTS AND METHODS: We assessed the specificity of carcinoembryonic antigen (CEA), cytokeratin-19 (CK-19), CK-20, gastrointestinal tumor-associated antigen-733.2 (GA733.2), and mucin-1 (MUC-1) in the blood of healthy donors (n = 13) and lymph nodes from patients without cancer (n = 3) by RT-PCR assay. The sensitivity of the RT-PCR assay for the target mRNA markers was assessed in breast cancer cell lines (n = 4), primary breast tumors (n = 8), and the frozen sections of SNs (n = 22) from 22 patients with American Joint Committee on Cancer (AJCC) stages I to IIIA breast cancer. RESULTS: CK-20 was the only mRNA marker not detected in lymph nodes or blood from patients without cancer. Both the blood and lymph nodes from patients without cancer expressed CEA, CK-19, GA733.2, and MUC-1 mRNA. All four breast cancer cell lines and six of eight primary breast tumors expressed all five mRNA markers. Expression of mRNA by the RT-PCR assay in the frozen-section SNs (n = 12) without metastases by conventional histopathology ranged from 8% (CK-20) to 92% (GA733.2). Detection of RT-PCR cDNA products in frozen-section SNs was increased with Southern blot analysis compared with ethidium bromide gel electrophoresis (EtBr) for all mRNA markers except CK-19. CONCLUSION: CEA, CK-19, GA733.2, and MUC-1 show no diagnostic value as mRNA markers for the detection of micrometastases by the RT-PCR assay because they are expressed in the blood and lymph nodes of patients without cancer. Further studies are needed to assess the sensitivity of CK-20 to detect micrometastases by the RT-PCR assay in the blood and frozen-section SNs of patients with breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
Morton, D. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040034005 · Cited by 4,371
Sentinel lymphadenectomy in breast cancer.
Giuliano, A. E., Jones, R. C., Brennan, M., & Statman, R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2345 · Cited by 1,096
Self-citationImproved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy
Giuliano, A. E., Dale, P. S., Turner, R. R., Morton, D. L., Evans, S. W., & Krasne, D. L. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00016 · Cited by 930
Self-citationSensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Datta, Y. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H., & Roth, M. S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.475 · Cited by 422
Karnofsky Memorial Lecture. Natural history of small breast cancers.
Hellman, S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2229 · Cited by 418
Gerhard, M., Juhl, H., Kalthoff, H., Schreiber, H. W., Wagener, C., & Neumaier, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.725 · Cited by 373
Burchill, S., Bradbury, M., Pittman, K., Southgate, J., Smith, B., & Selby, P. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.56 · Cited by 326
Zippelius, A., Kufer, P., Honold, G., Köllermann, M. W., Oberneder, R., Schlimok, G., Riethmüller, G., & Pantel, K. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2701 · Cited by 277
Prognostic Factors and Therapeutic Decisions in Axillary Node-Negative Breast Cancer
Elledge, R. M., & McGuire, W. L. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001221 · Cited by 257
Soeth, E., Vogel, I., Röder, C. H., et al. (1997) · PubMed · Cited by 217
Cited by
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis
Bustin, S. A., & Mueller, R. (2005) · Clinical Science · doi:10.1042/cs20050086 · Cited by 529
Detection and Clinical Importance of Micrometastatic Disease
Pantel, K., Cote, R. J., & Fodstad, O. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1113 · Cited by 493
Self-citationWhy the need for qPCR publication guidelines?—The case for MIQE
Bustin, S. A. (2010) · Methods · doi:10.1016/j.ymeth.2009.12.006 · Cited by 375
Metadata
- Authors
- Bostick, P. J., Chatterjee, S., Chi, D. D., Huynh, K. T., Giuliano, A. E., Cote, R., & Hoon, D. S.
- Venue
- Journal of Clinical Oncology
- Published
- 1998-08
- Volume
- 16
- Issue
- 8
- Pages
- 2632-2640
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1838509453
- Cited by
- 348
- References
- 15
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. https://app.cochat.ai/papers/10.1200/jco.1998.16.8.2632
- The paper
- Bostick, P. J., Chatterjee, S., Chi, D. D., Huynh, K. T., Giuliano, A. E., Cote, R., & Hoon, D. S. (1998). Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1998.16.8.2632
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.